Dolphin Medical Services reports standalone net loss of Rs 0.07 crore in the March 2022 quarter

Dolphin Medical Services reports standalone net loss of Rs 0.26 crore in the March 2021 quarter

Dolphin Medical Services reports standalone net profit of Rs 0.02 crore in the December 2020 quarter

Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Average profitability - not good, not bad

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Dolphin Medical Services Limited is engaged in providing medical laboratory and allied services. The Company provides a range of diagnostic services covering radiology and imaging, biochemistry, pathology and microbiology

Dolphin Medical Services Ltd

Dolphin Medical Services Ltd

Scorecard

News & Opinions

Dolphin Medical Services reports standalone net loss of Rs 0.07 crore in the March 2022 quarter

Dolphin Medical Services reports standalone net loss of Rs 0.26 crore in the March 2021 quarter

Dolphin Medical Services reports standalone net profit of Rs 0.02 crore in the December 2020 quarter